We found using BLI that mice treated with B7-H3-CXCR2 CAR T cells had significant inhibition of tumor growth, with 3 out of 7 mice experiencing complete tumor regression by day 39 after tumor injection. The gene discussed is CXCR2; the disease is neoplasm.